NAFDAC Directs Withdrawal of Teva Products in Nigerian Market

November 13, 2018 by PharmaTimes

In a move reminiscent of previous unsuccessful attempts by unscrupulous elements to promote fake Teva drug products in Nigeria, there has emerged recently what seems to be a determined effort to keep the unlawful business flourishing.
The National Agency for Food and Drug Administration and Control (NAFDAC’s) recent alert to the public on the existence of fake Teva Amlodipine, a prescription drug for the management and treatment of hypertension aptly captures this line of thinking.
The Director General of the agency Prof. Mojisola Adeyeye reportedly directed the withdrawal of all Teva products in circulation in the country even as the agency was quoted to have revoked the license of the pharmaceutical company linked with the latest discovery.
National Chairman of the Association of Community Pharmacists of Nigeria (ACPN), Pharm. Samuel Adekola, who confirmed the development however, issued a statement published on Pharma Frontiers, an online publication of distinguished pharmacists in Nigeria – urging members to comply immediately with the NAFDAC directive.

See products below…

Teva Amlodipine 10MG

Teva Amlodipine 5MG

Teva Lisinopril 5MG

Teva Lisinopril 10MG

Pharm. Adekola who further said that NAFDAC boss contacted him on phone over the development also assured that ACPN is determined to partner the pharmaceutical regulatory agency in safeguarding the health of Nigerians.
By implication, all Teva drug products currently in circulation in the Nigerian market are affected by the NAFDAC directive at least for now.
Dozens of ACPN members and other pharmacists operating in the country who responded to the directive by the ACPN leader, applauded authorities in NAFDAC for the prompt action it took over the development
The directive of NAFDAC is coming on the heels of the declaration by the newly elected President of the Pharmaceutical Society of Nigeria (PSN), Mazi Sam Ohuabunwa that the umbrella body of pharmacists in Nigeria is desirous of partnering NAFDAC and Pharmacists Council of Nigeria (PCN) to wage effective war against circulation of fake medicines in the country.
According to pharmaceutical industry experts, a combined effort of PCN, NAFDAC and PSN in confronting the menace of fake drugs in the country is what is needed to discourage existing and potential investors in the business.
A number of commentators have argued that the criminal elements involved in the importation of Teva anti-hypertensive products had cashed in on the porousness of the Nigerian borders to freight in the unregistered products, and therefore appealed to authorities in government to tighten security at the nation’s borders.
The frequency with which Teva products are being mentioned by NAFDAC for issues bodering on illegality is raising eyebrows among members of the public.
It would be recalled that in November 2016, NAFDAC sealed 5 shops in the popular Idumota market in Lagos over unregistered Teva Amlodopine and Lisinopril anti-hypertensive drugs circulating in the country.
A source at the agency who pleaded anonymity had disclosed to PharmaTimes that NAFDAC’s actions followed a discovery that the two products were not registered by it and may have been brought into the country through unauthorised channels by unscrupulous promoters of counterfeit medicines in the country.